Andrew Frankart receives $729,000 ACS/ASTRO Clinician Scientist Development Grant

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Andrew Frankart received a five-year, $729,000 American Cancer Society/American Society for Radiation Oncology Clinician Scientist Development Grant to lead a clinical trial at the University of Cincinnati Cancer Center that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Harold P. Freeman, a surgeon who started his career in Harlem, where, in addition to performing surgeries, he pioneered the system of patient navigation, and who studied health disparities and served as president of the American Cancer Society and chair of the President’s Cancer Panel, died on Aug. 11. He was 93.
In 1971, the National Cancer Act set the United States on a path to confront one of its most formidable public health challenges. More than five decades later, the progress is undeniable. The latest 2026 report from the American Cancer Society shows continued declines in overall cancer mortality and improvements in survival for many major cancer types. Recent advances in early detection, prevention, and treatment are saving lives.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login